https://www.selleckchem.com/pr....oducts/qnz-evp4593.h
A comparison between 168 responders and 50 non-responders at baseline and 12-week follow-up showed that GPx activity decreased in both groups after treatment. Moreover, GPx activity decreased less in responders and was higher in responders than in non-responders at follow-up. These results demonstrate that the redox regulatory system and antioxidant defense enzymes may have predictive value for the response of ANFE patients to risperidone treatment.Spinal cord injury (SCI) leads to severe impairment in cardiovascular control, common
Like
Comment
Share
